Dr. Aranda is an top expert in the area of pharmacology in the pediatric population. His issue has knowledgeable authors presenting clinical reviews on a wide variety of topics, from "hot areas " of drug therapy to drug abuse in children as well as current areas of debate in neonatal drug therapy. Articles are devoted to the following topics: New and Current Drug Therapies For Asthma In Children; Psychopharmacology Of Bipolar Disorders in Children and Adolescents; Designer Drug Abuse in School Children; Dietary Supplements in Children; Anticoagulant Therapies in Children; New Antimicrobials for Gram-Positive Infections in Children; Probiotics in Newborns And Children; Anticonvulsant Therapies in Newborns and Children; Immunomodulator Drug Therapies in Inflammatory Bowel Diseases in Children; Non-Steroidal Anti-Inflammatory Drugs in Newborns and Children; Metformin Use in Pre-Diabetic Children and Adolescents; Problems in Drug Dosing of Obese Children; Inhaled Drugs and Systemic Steroids for Bronchopulmonary Dysplasia; Antifungal Drugs in Newborns and Children; Antiviral Drugs In Newborns and Children; and Development of Drug Therapies for Newborns and Children. Readers will come away with the latest clinical information to help inform them when diagnosing and prescribing for children.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. CME Accreditation Page - p. iii 6. Contributors - p. v 7. Forthcoming Issues - p. xiv 8. Preface - p. xv 9. Development of Drug Therapies for Newborns and Children: The Scientific and Regulatory Imperatives - p. 1185 10. Approaching Current and New Drug Therapies for Pediatric Asthma - p. 1197 11. Psychopharmacology of Bipolar Disorders in Children and Adolescents - p. 1209 12. New Psychoactive Substances in Pediatric Patients - p. 1223 13. Dietary Supplements in Children - p. 1243 14. Anticoagulation Therapies in Children - p. 1257 15. Probiotics in Newborns and Children - p. 1271 16. Drug Treatment of Seizures and Epilepsy in Newborns and Children - p. 1291 17. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: History and Future Directions - p. 1309 18. Non-steroidal Anti-inflammatory Drugs in Newborns and Infants - p. 1327 19. Metformin Use in Children and Adolescents with Prediabetes - p. 1341 20. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia - p. 1355 21. New Antimicrobial Agents for the Treatment of Staphylococcal Infections in Children - p. 1369 22. Antifungal Drugs in Newborns and Children - p. 1389 23. Antiviral Drugs in Newborn and Children - p. 1403 24. Drug Dosing in Obese Children: Challenges and Evidence-Based Strategies - p. 1417
No hay muestra disponible
No hay ficha técnica disponible
Dr. Aranda is an top expert in the area of pharmacology in the pediatric population. His issue has knowledgeable authors presenting clinical reviews on a wide variety of topics, from "hot areas " of drug therapy to drug abuse in children as well as current areas of debate in neonatal drug therapy. Articles are devoted to the following topics: New and Current Drug Therapies For Asthma In Children; Psychopharmacology Of Bipolar Disorders in Children and Adolescents; Designer Drug Abuse in School Children; Dietary Supplements in Children; Anticoagulant Therapies in Children; New Antimicrobials for Gram-Positive Infections in Children; Probiotics in Newborns And Children; Anticonvulsant Therapies in Newborns and Children; Immunomodulator Drug Therapies in Inflammatory Bowel Diseases in Children; Non-Steroidal Anti-Inflammatory Drugs in Newborns and Children; Metformin Use in Pre-Diabetic Children and Adolescents; Problems in Drug Dosing of Obese Children; Inhaled Drugs and Systemic Steroids for Bronchopulmonary Dysplasia; Antifungal Drugs in Newborns and Children; Antiviral Drugs In Newborns and Children; and Development of Drug Therapies for Newborns and Children. Readers will come away with the latest clinical information to help inform them when diagnosing and prescribing for children.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. CME Accreditation Page - p. iii 6. Contributors - p. v 7. Forthcoming Issues - p. xiv 8. Preface - p. xv 9. Development of Drug Therapies for Newborns and Children: The Scientific and Regulatory Imperatives - p. 1185 10. Approaching Current and New Drug Therapies for Pediatric Asthma - p. 1197 11. Psychopharmacology of Bipolar Disorders in Children and Adolescents - p. 1209 12. New Psychoactive Substances in Pediatric Patients - p. 1223 13. Dietary Supplements in Children - p. 1243 14. Anticoagulation Therapies in Children - p. 1257 15. Probiotics in Newborns and Children - p. 1271 16. Drug Treatment of Seizures and Epilepsy in Newborns and Children - p. 1291 17. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: History and Future Directions - p. 1309 18. Non-steroidal Anti-inflammatory Drugs in Newborns and Infants - p. 1327 19. Metformin Use in Children and Adolescents with Prediabetes - p. 1341 20. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia - p. 1355 21. New Antimicrobial Agents for the Treatment of Staphylococcal Infections in Children - p. 1369 22. Antifungal Drugs in Newborns and Children - p. 1389 23. Antiviral Drugs in Newborn and Children - p. 1403 24. Drug Dosing in Obese Children: Challenges and Evidence-Based Strategies - p. 1417
No hay muestra disponible
No hay ficha técnica disponible
